Uncategorized
STAAR works to correct observed deficits in good manufacturing practices
The FDA may withhold approval of new products such as the toric ICL or take additional regulatory or legal action against STAAR Surgical, unless and until STAAR corrects outstanding issues to the FDA’s satisfaction, according to a form the company issued to the Securities and Exchange Commission.